CBD Hemp Oil Market Size, Trend, Share and Forecast 2032

CBD Hemp Oil Market Overview:

The global CBD Hemp Oil Market size was estimated at USD 2627 million in 2025 and is expected to reach USD 5746.48 million by 2032, growing at a CAGR of 11.83% from 2025 to 2032. Growth is primarily driven by widening consumer adoption of CBD-based wellness routines across stress management, sleep support, skin health, and functional nutrition, supported by expanding retail availability and stronger product standardization. Commercial momentum is also reinforced by brand investments in compliance-grade sourcing, lab testing, and differentiated formats that improve trust and repeat purchasing across major consumption regions.

Key Market Trends & Insights

• The market is projected to expand from USD 2627 million (2025) to USD 5746.48 million (2032), reflecting 11.83% CAGR (2025–2032).
• Hemp-derived CBD accounted for the largest share of 58.40% in 2025, supported by broader mainstream acceptance and scalable cultivation economics.
• B2B (Business-to-Business) represented 57.20% in 2025, reflecting strong bulk procurement by supplement, personal care, and functional food manufacturers.
• Pharmaceuticals held 44.60% share in 2025, supported by demand for consistent dosing formats and higher-quality extraction and testing requirements.
• North America led with 45.90% share in 2025, followed by Europe at 27.10% and Asia Pacific at 18.60%, showing concentration in mature consumer markets while APAC accelerates.

Segment Analysis

CBD hemp oil demand is increasingly shaped by routine wellness use-cases, where consumers prioritize transparent labeling, third-party testing, and predictable effects. Product differentiation is moving from basic tinctures toward targeted formulations-sleep, calm, recovery, skin, and functional blends-supported by stronger brand storytelling and ingredient traceability. As the category matures, purchasing behavior is also shifting toward trusted retail, subscription models, and repeat regimens that favor consistent quality and recognizable brands.

Commercially, manufacturers are balancing compliance, supply consistency, and cost by strengthening hemp sourcing strategies and investing in extraction, purification, and quality systems. Larger buyers increasingly prefer suppliers that can provide documentation, batch-level testing, and scalable production to reduce risk across regulated channels. Over the forecast period, format innovation and channel expansion are expected to remain central to value capture, especially where regulations enable broader commercialization and cross-category product integration.

By Source Insights

Hemp-Derived accounted for the largest share of 58.40% in 2025. It leads because hemp supply chains are more scalable and widely accepted for mainstream consumer products, enabling consistent input availability for brands and manufacturers. Many companies prioritize hemp-derived inputs to reduce regulatory complexity and maintain THC-threshold compliance in broader markets. Improved cultivation practices and extraction efficiencies also support more predictable quality and pricing for high-volume product lines.

By Application Insights

Pharmaceuticals accounted for the largest share of 44.60% in 2025. This leadership is supported by demand for controlled formulations where consistency, dosage precision, and safety testing are critical to adoption. Pharmaceutical-oriented buyers typically require stronger quality assurance and documentation, which increases the competitiveness of suppliers with robust standards and validated processes. Continued clinical interest and physician-supervised use-cases also reinforce steady demand for medical-grade oils and derivatives.

By Distribution Channel Insights

B2B (Business-to-Business) accounted for the largest share of 57.20% in 2025. B2B remains dominant because finished-product manufacturers in supplements, cosmetics, functional foods, and wellness procure CBD inputs at scale to support brand portfolios. As compliance requirements tighten, supplier qualification, testing transparency, and dependable batch consistency become decisive differentiators in B2B procurement. Contract manufacturing and private-label production further amplify bulk demand, sustaining B2B leadership even as DTC grows.

CBD Hemp Oil Market Drivers

Expansion Of Wellness-Focused Consumption

CBD hemp oil adoption is rising as consumers increasingly incorporate wellness products into daily routines for stress relief, sleep support, recovery, and general wellbeing. Broader product accessibility across retail and digital channels improves trial and repeat purchases, especially for oils, capsules, topicals, and blends. More brands are investing in clearer dosing guidance and product education, which reduces uncertainty for first-time buyers. This driver is reinforced by growing interest in plant-based ingredients and functional health positioning across multiple end-use categories.

Product Standardization And Quality Transparency

The market benefits as producers improve consistency through better extraction methods, purification processes, and batch-level testing practices. Standardization builds consumer trust and supports wider distribution through reputable retail chains and professional channels. Brands differentiating on traceability, lab reports, and formulation integrity often achieve stronger retention and premium positioning. As more buyers become quality-sensitive, suppliers with documented compliance systems and stable sourcing are better positioned to capture long-term contracts and expand across regulated segments.

• For instance, CV Sciences, Inc. (PlusCBD) implemented a supercritical CO₂ extraction system operating at 3,500 psi and 45°C, achieving ≥98% cannabinoid recovery efficiency and <0.5% residual solvent levels across 150+ batches in 2024, with every batch assigned a QR-code-linked Certificate of Analysis (CoA) showing 100% compliance with USDA hemp rules and California Prop 65 limits for heavy metals and pesticides .

Channel Expansion And Omnichannel Availability

Distribution is widening through a mix of specialty retail, pharmacy-led expansion in select markets, online commerce, and brand-owned DTC platforms. Omnichannel strategies strengthen customer acquisition and enable targeted marketing, subscriptions, and personalized regimens that improve lifetime value. Retail placement can accelerate mainstream awareness, while e-commerce supports broader assortment and convenient repurchase. This diversification reduces reliance on any single channel and allows brands to adjust quickly to changing regulations, consumer preferences, and competitive pressure.

Cross-Category Integration In Consumer Products

CBD hemp oil is increasingly incorporated into personal care, nutraceuticals, functional food and beverage concepts, and pet wellness offerings where permitted. This cross-category integration expands total addressable demand and encourages innovation in formats, flavors, and functional combinations. Large consumer brands and contract manufacturers can accelerate scale by integrating CBD derivatives into established product lines. As formulation capabilities mature, differentiated use-case products calm, sleep, skin soothing, and mobility support help companies defend margins and reduce direct price competition.

• For instance, Charlotte’s Web has built an omnichannel presence with products distributed through more than 15,000 retail locations and over 8,000 healthcare practitioners, while also selling directly through its online platform. Similarly, Medterra stated that its products were available in more than 14,000 retail locations globally through partners including CVS, Kroger, and Walgreens, illustrating how pharmacy and mass-retail access can complement direct online sales.

CBD Hemp Oil Market Challenges

Regulatory uncertainty remains a key obstacle because rules for cannabinoid products vary significantly by country and can change rapidly. Companies must manage evolving requirements around THC thresholds, allowable claims, testing standards, labeling, and permissible channels, which increases operational cost and slows expansion. Compliance complexity also creates distribution barriers, particularly for food and beverage applications where approvals may be stricter. These factors can limit product variety and delay mainstream adoption in certain markets.

• For instance, in 2023 the U.K. Food Standards Agency (FSA) removed numerous CBD food and drink products from its public “list of accepted CBD novel food applications” after determining they no longer met submission requirements, effectively blocking their sale in mainstream retail and foodservice channels.

Quality inconsistency and consumer trust issues also challenge growth, especially when low-cost products enter the market without robust testing and traceability. Variability in potency, contaminants, or inaccurate labeling can lead to reputational damage across the broader category. Brands must invest in quality systems, supplier audits, and transparent communication to protect credibility. Competitive intensity further pressures pricing, making it difficult for smaller companies to sustain marketing and compliance investments at scale.

CBD Hemp Oil Market Trends and Opportunities

Product innovation is accelerating toward targeted and premiumized offerings that emphasize specific outcomes such as sleep support, calm, recovery, and skin health. Brands are increasingly using cleaner ingredient decks, functional combinations, and differentiated delivery forms to improve consumer experience and retention. As the category matures, opportunities expand for clinically oriented positioning, measured dosing formats, and quality-led portfolios that appeal to cautious mainstream buyers. Companies that build trust through documentation and consistency can compete beyond price.

• For instance, in March 2024 Charlotte’s Web launched “Stay Asleep” CBN gummies delivering a 20 mg dose of cannabinol (CBN) per serving, backed by a placebo-controlled, peer-reviewed clinical study showing improved sleep continuity in adults who wake during the night.

Partnerships and consolidation are creating opportunities to scale distribution, secure reliable supply, and broaden product portfolios across channels. Strategic collaborations with retailers, manufacturers, and wellness platforms can improve market access and lower customer acquisition costs. In parallel, B2B growth opportunities remain strong where suppliers provide standardized inputs, technical support, and regulatory documentation for large brand customers. Expansion into new geographies will favor companies with adaptable compliance strategies and proven quality controls.

Regional Insights

North America

North America accounted for 45.90% share in 2025, supported by strong consumer awareness, broad product availability, and established retail and online distribution networks. The region benefits from active brand competition focused on quality, transparency, and differentiated wellness positioning. Manufacturers and retailers also drive category visibility through product education, merchandising, and format expansion. Demand remains strong across oils, capsules, topicals, and wellness blends, with continued emphasis on trust, testing, and consistent dosing.

Europe

Europe held 27.10% share in 2025, shaped by uneven regulatory frameworks and varying channel access across countries. Growth is supported by increasing consumer interest in natural wellness products and gradual expansion of compliant product offerings. Brands that adapt labeling, claims, and THC-compliance requirements to local regulations gain advantage in distribution and repeat purchasing. Market development is also influenced by pharmacy and specialty retail dynamics, where credibility and product consistency play a major role.

Asia Pacific

Asia Pacific captured 18.60% share in 2025, with growth driven by evolving acceptance, rising disposable income, and expanding wellness consumption in select markets. While regulation can be restrictive in parts of the region, demand is building where compliant formats are available and consumer education improves. Market momentum is often strongest for personal care and nutraceutical-style positioning, supported by e-commerce and cross-border sales models. Companies that navigate approvals and localization can unlock significant upside as the region matures.

Latin America

Latin America represented 5.80% share in 2025, reflecting early-stage commercialization and uneven regulatory progress across countries. Growth is supported by rising awareness of CBD wellness use-cases and gradual expansion of medical and compliant consumer pathways. Distribution often depends on trustworthy retail networks, professional channels, and clear product documentation. As frameworks stabilize, opportunities are likely to expand for standardized oils and value-priced wellness formats, especially through online channels.

Middle East & Africa

The Middle East and Africa accounted for 2.60% share in 2025, constrained by restrictive policies in many countries and limited formal commercialization routes. Where medical or tightly controlled use is permitted, demand favors higher-compliance products with strong documentation and quality assurance. Market growth depends heavily on regulatory clarity, import permissions, and channel development through approved distributors. Over time, selective liberalization could support niche growth, especially for medical and premium wellness categories.

Competitive Landscape

Competition in the CBD hemp oil market is shaped by product quality differentiation, brand trust, and the ability to navigate compliance requirements across diverse jurisdictions. Companies compete through third-party testing transparency, traceable sourcing, specialized formulations, and expansion across retail and direct-to-consumer channels. Portfolio breadth across oils, gummies, topicals, capsules, and functional blends is used to address multiple wellness needs and defend pricing. Strategic partnerships, retailer access, and manufacturing capabilities are increasingly important as the market consolidates.

Charlotte's Web Holdings, Inc. typically competes through a quality-led approach built on brand recognition, product consistency, and broad consumer wellness positioning. The company’s strategy often emphasizes traceability, testing transparency, and a diversified portfolio that spans key wellness use-cases. Expansion into wider retail footprints and continued formulation innovation can strengthen visibility and repeat purchase behavior. Sustained competitiveness depends on maintaining quality differentiation while scaling distribution and managing regulatory complexity across channels.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Charlotte's Web Holdings, Inc.
• CV Sciences, Inc.
• Medterra CBD
• Green Roads Inc.
• Joy Organics
• CBDfx
• NuLeaf Naturals
• Aurora Cannabis Inc.
• Canopy Growth Corporation
• Elixinol LLC
• Endoca BV
• Hemp Bombs
• Pure Spectrum
• Medical Marijuana, Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Developments

• In January 2026, cbdMD, Inc. finalized its strategic acquisition of Bluebird Botanicals, a well-established CBD brand with AS-status full-spectrum CBD products. This deal encompasses Bluebird's e-commerce operations and valuable intellectual property, enabling cbdMD to broaden its revenue stream and capitalize on operational synergies. The integration is currently in progress, with management expecting improved earnings through cost savings and enhanced distribution.
• In February 2026, cbdMD expanded distribution for its Herbal Oasis THC-infused social seltzer (which contains CBD hemp oil alongside hemp-derived THC and CBG) into Louisiana through an expanded partnership with Morales Beverage Group (MBG). Initial shipments began leveraging MBG's statewide infrastructure after strong early performance in Texas, tapping into the rapidly growing THC beverage market projected to reach $3.5 billion by 2030.
• In March 2026, High Tide Inc. and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals joined the National Compassionate Care Council (NCCC) as founding members alongside Lazarus Naturals, Medterra CBD, Feals, Tilray Inc., and others. This partnership aims to improve patient access to cannabinoid therapies by modernizing healthcare standards and advancing evidence-based policy, strengthening the medical legitimacy of CBD hemp oil products.
• In March 2026, Splash Beverage Group signed a Letter of Intent for a strategic partnership with Medterra CBD LLC, positioning both companies to drive category leadership in the emerging cannabinoid wellness market. Through this proposed partnership, the companies plan to leverage operational scale and participate in the CMS CBD pilot initiative, which could represent a meaningful long-term growth opportunity as Medicare evaluates CBD reimbursement pathways.

Report Scope  

Segmentation

By Source

• Hemp-Derived
• Marijuana-Derived

By Application

• Personal Care & Cosmetics
• Nutraceuticals & Dietary Supplements
• Food & Beverages
• Pharmaceuticals
• Pet Care

By Distribution Channel

• B2C (Business-to-Consumer)
• B2B (Business-to-Business)

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.